These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 5704263

  • 1. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R, Hueber EF.
    Wien Med Wochenschr; 1968 Nov 23; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract] [Full Text] [Related]

  • 2. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 3. [Benziodarone in the basic treatment of gout].
    Ryckewaert A, Puel M, Kuntz D.
    Rev Rhum Mal Osteoartic; 1972 Jan 16; 39(1):33-9. PubMed ID: 5079688
    [No Abstract] [Full Text] [Related]

  • 4. [Hyperuricemia and benziodarone].
    Haddad N, Zamouri A, Naccache S.
    Tunis Med; 1973 Jan 16; 51(2):103-4. PubMed ID: 4784400
    [No Abstract] [Full Text] [Related]

  • 5. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 6. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Nov 22; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 7. [Action of benziodarone on hyperuricemia in gout].
    Cottet J, Vittu C.
    Presse Med (1893); 1967 May 27; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO, Rodhain J.
    Rev Rhum Mal Osteoartic; 1968 Mar 27; 35(3):98-115. PubMed ID: 5302427
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N, Griebsch A, Fink JK.
    Dtsch Med Wochenschr; 1970 Nov 27; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract] [Full Text] [Related]

  • 10. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
    Blétry O, Cartier P, Hamet M, Clauvel JP.
    Nouv Presse Med; 1974 Apr 20; 3(16):995-9. PubMed ID: 4836472
    [No Abstract] [Full Text] [Related]

  • 11. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F.
    Fortschr Med; 1978 Aug 24; 96(32):1619-21. PubMed ID: 680625
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of hyperuricemia with benziodarone].
    Ravault PP, Vignon G, Lejeune E, Bouvier M, Queneau P.
    Presse Therm Clim; 1970 Aug 24; 107(2):74-9. PubMed ID: 5468122
    [No Abstract] [Full Text] [Related]

  • 13. [Gout treatment with a dibromine derivative of benzofuran].
    Delbarre F, Auscher C, Saporta L, de Grey A, Danchot J.
    Rev Rhum Mal Osteoartic; 1973 Apr 24; 40(4):275-7. PubMed ID: 4716906
    [No Abstract] [Full Text] [Related]

  • 14. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A.
    Rein Foie; 1967 Apr 24; 10():273-92. PubMed ID: 6081455
    [No Abstract] [Full Text] [Related]

  • 15. [Benziodarone in the treatment of hyperuricemia].
    Ravera M.
    Clin Ter; 1970 Mar 15; 52(5):407-16. PubMed ID: 5421984
    [No Abstract] [Full Text] [Related]

  • 16. [Benziodarone (Amplivix) in the treatment of hyperuricemia].
    Antila V, Elsilä M.
    Duodecim; 1969 Mar 15; 85(7):428-30. PubMed ID: 5799173
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R, Pagnan A, Fedele D, Novello M, Crepaldi G.
    Policlinico Med; 1972 Mar 15; 79(3):151-64. PubMed ID: 5051107
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of benziodarone on hyperuricemia].
    Josef H, Cossermelli W, Debes AC, Kopersztych S.
    AMB Rev Assoc Med Bras; 1969 Sep 15; 15(9):381-2. PubMed ID: 5309746
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
    Barcelo P, Santamaria A.
    Verh Dtsch Ges Rheumatol; 1969 Sep 15; 1():361-70. PubMed ID: 5403652
    [No Abstract] [Full Text] [Related]

  • 20. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A, Giudicelli CP.
    Sem Hop Ther; 1976 Sep 15; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.